The BCR-Abl gene is associated with a dysregulation of TK function and subsequently leads to malignant transformation in chronic myelogenous leukemia (CML) [19], [20]. This evidence concerns the gene TKT and chronic myelogenous leukemia, BCR-ABL1 positive.